XM no presta servicios a los residentes de Estados Unidos de América.
I
I

Incyte


Noticias

U.S. BlackRock, Goldman Sachs, Netflix

U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix July 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BlackRock, Goldman Sachs and Netflix, on Tuesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : RBC raises target price to $487 from $480 * BlackRock BLK.N : JP Morgan raises target price to $774 from $756 * Goldman Sachs GS.N : HSBC raises target price to $527 from $493 * Moody's Corp MCO.N : JP Morgan rai
A
A
B
C
G
I
N
A
D
G
S
W
A
P

U.S. STOCKS Helios Technologies, Indivior, Principal Financial

BUZZ-U.S. STOCKS ON THE MOVE-Helios Technologies, Indivior, Principal Financial Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hovered at record highs on Tuesday, propelled by gains in Nvidia and other megacaps, as U.S.
I
I
N
P
T
C
U
U
S

U.S. STOCKS Tesla, Archer Aviation, Novo Nordisk

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Archer Aviation, Novo Nordisk Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 edged up on Tuesday, boosted by gains in Tesla and megacap stocks, while the Dow was flat with investors assessing Federal Reserve Chairman Jerome Powell's comments on the need for more evidence before cutting rates.
I
P
P
P
P
T
L
O
W
U
U
U

U.S. STOCKS Tesla, Pure Storage, Rivian

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Pure Storage, Rivian Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street indexes traded lower on Tuesday after Federal Reserve Chairman Jerome Powell said more evidence was needed before cutting interest rates, while gains in Tesla shares kept losses in check.
I
P
P
T
L
O
W
U
U
U

U.S. STOCKS PayPal, Paramount Global, Novo Nordisk

BUZZ-U.S. STOCKS ON THE MOVE-PayPal, Paramount Global, Novo Nordisk Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was on track for a lower open on Tuesday as megacap stocks retreated after a strong session, with additional caution creeping in ahead of jobs opening data and comments from Federal Reserve Chairman Jerome Powell later in the day.
I
P
T
U
R

U.S. STOCKS Atlassian, Comerica, Tesla

BUZZ-U.S. STOCKS ON THE MOVE-Atlassian, Comerica, Tesla Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures fell on Tuesday as megacap stocks retreated after a strong session, with additional caution creeping in ahead of jobs opening data and comments from Federal Reserve Chairman Jerome Powell later in the day.
I
T
U
R

Incyte drops after BMO downgrades to 'underperform'

BUZZ-Incyte drops after BMO downgrades to 'underperform' ** Shares of drugmaker Incyte Corp INCY.O down ~3% at $59.01 in premarket trading ** BMO Capital Markets cuts stock to "underperform" from "market perform"; trims PT to $48 from $52 ** Says co's $2 bln Dutch auction has cut capacity to acquire while generating minimal incremental value for sh
I

U.S. Deckers Brands, Nvidia, Workday

U.S. RESEARCH ROUNDUP-Deckers Brands, Nvidia, Workday May 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Deckers Brands, Nvidia and Workday, on Friday. HIGHLIGHTS * Deckers Brands DECK.N : Barclays raises target price to $1089 from $1026 * Enersys ENS.N : BTIG cuts to neutral from buy * Nvidia Corp NVDA.O : Deutsche Bank raises target price to $1000 * Ulta Beauty Inc ULTA.O : Jefferies cuts target price to $412 fr
A
I
I
N
A
R
U

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Incyte Corp INCY.OQ +8.2% Moderna Inc MRNA.OQ +6.3% Walgreens Boots Alliance Inc WBA.OQ +5.6% American Airlines Group Inc AAL.OQ +4.1% Carmax Inc KMX.N +3.9% Bottom Performers Percent Change Mettler-Toledo International Inc MTD.N -4.0%
I
W
A
U
H
C
M

U.S. STOCKS Annexon, MKS Instruments, Robinhood

BUZZ-U.S. STOCKS ON THE MOVE-Annexon, MKS Instruments, Robinhood Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes edged higher on Monday, nearing record highs after a recent run of gains, as investors awaited key inflation figures this week to gauge the likelihood of interest rate cuts in 2024. .N At 11:58 a.m.
A
C
G
G
I
N
U
U
H
C
M

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Incyte Corp INCY.OQ +7.4% Carmax Inc KMX.N +5.1% Walgreens Boots Alliance Inc WBA.OQ +4.6% Moderna Inc MRNA.OQ +4.5% American Airlines Group Inc AAL.OQ +4.3% Bottom Performers Percent Change Mettler-Toledo International Inc MTD.N -2.5%
I
W
A
U
H
U
C
M

Incyte jumps on $2 bln share buyback plan

BUZZ-Incyte jumps on $2 bln share buyback plan ** Shares of Incyte INCY.O jump 6.2% premarket to $56.35, over 1-mth high, as biopharma firm announces $2 bln stock buyback plan ** Co commences modified "Dutch Auction" tender offer to repurchase shares for aggregate purchase price of up to $1.672 bln ** In addition, co entered into stock purchase agreement with Baker Bros Advisors, top INCY holder (per LSEG), to repurchase up to $328 worth of shares to enable the investment manager to maintain its
I

Incyte Announces Intention To Buy Back Up To $2.0 Billion Of Its Common Stock

BRIEF-Incyte Announces Intention To Buy Back Up To $2.0 Billion Of Its Common Stock May 13 (Reuters) - Incyte Corp INCY.O : INCYTE ANNOUNCES INTENTION TO BUY BACK UP TO $2.0 BILLION OF ITS COMMON STOCK INCYTE CORP - INCYTE COMMENCES DUTCH AUCTION TENDER OFFER TO REPURCHASE UP TO $1.67 BILLION OF OUTSTANDING COMMON SHARES Source text for Eikon: ID:n
I

U.S. STOCKS Molson Coors, Starbucks, Warner Bros Discovery

BUZZ-U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday with caution prevailing ahead of the Federal Reserve's interest-rate decision and as stronger-than-expected labor costs hinted at persistent inflation.
A
I
P
P
S
T
A
S
U
U
E
R
G
L
M
T

U.S. STOCKS Zebra Technologies, Ecolab, American Electric Power

BUZZ-U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday with caution prevailing ahead of the Federal Reserve's interest-rate decision and as stronger-than-expected labor costs hinted at persistent inflation.
I
P
P
T
C
S
U
U
E
R
G
L
T

Incyte Corp reports results for the quarter ended in March - Earnings Summary

Incyte Corp reports results for the quarter ended in March - Earnings Summary Incyte Corp INCY.OQ reported quarterly adjusted earnings of 64 cents​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of 37 cents. The mean expectation of twenty analysts for the quarter was for earnings of 84 cents per share.
I

Incyte misses quarterly profit on weak sales of lead drug

Incyte misses quarterly profit on weak sales of lead drug April 30 (Reuters) - Incyte Corp INCY.O on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition from newly approved drugs, which could impact sales of Jakafi, the company's biggest-selling drug, as it nears the loss of exclusivity later this decade.
I
M
N

U.S. STOCKS LendingTree, Leidos, Roku

BUZZ-U.S. STOCKS ON THE MOVE-LendingTree, Leidos, Roku Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Futures tracking Wall Street's main indexes were subdued on Tuesday as investors refrained from placing big bets ahead of the Federal Reserve's interest rate decision and kept a close eye on a stream of earnings updates.
I
P
T
C
S
U
R
L

Incyte Corp falls on lower-than-expected revenue, profit

BUZZ-Incyte Corp falls on lower-than-expected revenue, profit ** Shares of drugmaker Incyte Corp INCY.O fall 2.9% to $51 premarket ** Co reports 9% growth in Q1 revenue of $880.9 mln, but misses analysts' estimates of $923.6 -LSEG data ** Posts Q1 adj.profit of 64 cents per share, also missing estimates of 84 cents per share- LSEG data ** Revenue f
I

Incyte Q1 Adjusted EPS USD 0.64 Vs. IBES Estimate USD 0.84

BRIEF-Incyte Q1 Adjusted EPS USD 0.64 Vs. IBES Estimate USD 0.84 Apr 30 (Reuters) - Incyte Q1 operating income USD 91.898 million. Q1 revenue USD 880.889 million vs. IBES estimate USD 923.6 million Q1 adjusted operating income USD 161.183 million vs. IBES estimate USD 206.3 million Q1 EPS USD 0.75
I



Condiciones

Activos populares

Descargo de responsabilidades: Cada una de las entidades de XM Group proporciona un servicio de solo ejecución y acceso a nuestra plataforma de trading online, permitiendo a una persona ver o usar el contenido disponible en o a través del sitio web, sin intención de cambiarlo ni ampliarlo. Dicho acceso y uso están sujetos en todo momento a: (i) Términos y Condiciones; (ii) Advertencias de riesgo; y (iii) Descargo completo de responsabilidades. Por lo tanto, dicho contenido se proporciona exclusivamente como información general. En particular, por favor tenga en cuenta que, los contenidos de nuestra plataforma de trading online no son ni solicitud ni una oferta para entrar a realizar transacciones en los mercados financieros. Operar en cualquier mercado financiero implica un nivel de riesgo significativo para su capital.

Todo el material publicado en nuestra plataforma de trading online tiene únicamente fines educativos/informativos y no contiene –y no debe considerarse que contenga– asesoramiento ni recomendaciones financieras, tributarias o de inversión, ni un registro de nuestros precios de trading, ni una oferta ni solicitud de transacción con instrumentos financieros ni promociones financieras no solicitadas.

Cualquier contenido de terceros, así como el contenido preparado por XM, como por ejemplo opiniones, noticias, investigaciones, análisis, precios, otras informaciones o enlaces a sitios de terceros que figuran en este sitio web se proporcionan “tal cual”, como comentarios generales del mercado y no constituyen un asesoramiento en materia de inversión. En la medida en que cualquier contenido se interprete como investigación de inversión, usted debe tener en cuenta y aceptar que dicho contenido no fue concebido ni elaborado de acuerdo con los requisitos legales diseñados para promover la independencia en materia de investigación de inversiones y, por tanto, se considera como una comunicación comercial en virtud de las leyes y regulaciones pertinentes. Por favor, asegúrese de haber leído y comprendido nuestro Aviso sobre investigación de inversión no independiente y advertencia de riesgo en relación con la información anterior, al que se puede acceder aquí.

Advertencia de riesgo: Su capital está en riesgo. Los productos apalancados pueden no ser adecuados para todos. Por favor, tenga en cuenta nuestra Declaración de riesgos.